Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Sarah L Anderson"'
Autor:
Sarah L Anderson, Joel C Marrs
Publikováno v:
Drugs in Context, Vol 12, Pp 1-8 (2023)
One in ten adults worldwide is living with diabetes, with 95% having type 2 diabetes (T2D). Sustained glycaemic control in people with T2D is difficult to achieve despite recent advances in T2D management with the advent of glucagon-like peptide 1 re
Externí odkaz:
https://doaj.org/article/ccf24655131449448b36d7bef1262547
Autor:
Sarah L Anderson, Joel C Marrs
Publikováno v:
Drugs in Context, Vol 11, Pp 1-12 (2022)
Atherosclerotic cardiovascular disease (ASCVD) commonly affects people with type 2 diabetes (T2D). Historically, traditional cardiovascular (CV) risk-lowering therapies in patients with T2D and ASCVD have included antiplatelet agents, blood pressure-
Externí odkaz:
https://doaj.org/article/7aaf37606bde4ec2a75b64c836f891a8
Publikováno v:
Drugs in Context, Vol 10, Pp 1-5 (2021)
The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as well as in vaccine and drug development. Nevertheless, several other advancements in variou
Externí odkaz:
https://doaj.org/article/3359a66d85574a359a072d24e16fb7e9
Autor:
Joel C Marrs, Sarah L Anderson
Publikováno v:
Drugs in Context, Vol 9, Pp 1-10 (2020)
More than 422 million people worldwide have diabetes, with 90–95% having type 2 diabetes (T2D). Glycemic control of T2D has demonstrated reductions in microvascular complications but recent data have demonstrated improvements in macrovascular outco
Externí odkaz:
https://doaj.org/article/7c365927fc0846798a822b35741dcadc
Autor:
Joel C Marrs, Sarah L Anderson
Publikováno v:
Drugs in Context, Vol 9, Pp 1-9 (2020)
Cardiovascular disease (CVD) is the leading cause of death worldwide and one key factor associated with the increased CVD risk is dyslipidemia. Statin therapy remains the first-line treatment to manage dyslipidemia, yet many patients do not achieve o
Externí odkaz:
https://doaj.org/article/a52df432d823429e9797d1b9616daa2f
Autor:
Sarah L Anderson, Joel C Marrs
Publikováno v:
Drugs in Context, Vol 7, Pp 1-7 (2018)
Hypertension (HTN) is a common disease state associated with extensive morbidity and mortality worldwide. It is often difficult for patients with HTN to achieve and maintain a goal blood pressure (BP), despite there being many effective treatment opt
Externí odkaz:
https://doaj.org/article/f73218bfaa384a5fb036163edbc1edd0
Publikováno v:
Child Psychiatry Hum Dev
Maternal warmth has been identified as a contributing factor to the development of child anxiety; however, no studies to date have examined observed maternal warmth longitudinally in this relationship. The present study addressed this knowledge gap b
Autor:
Stephanie R. Witek, S. Mimi Mukherjee, Kim Thrasher, Adriane N. Irwin, Jennifer N. Clements, Roshni P. Emmons, Sarah L. Anderson, Scott A. Coon, Marissa Chow, Julie M. Sease
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:390-405
Publikováno v:
American Journal of Health-System Pharmacy
American Journal of Health-System Pharmacy: AJHP
American Journal of Health-System Pharmacy: AJHP
Publikováno v:
Drugs in Context, Vol 10, Pp 1-5 (2021)
Drugs in Context
Drugs in Context
The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as well as in vaccine and drug development. Nevertheless, several other advancements in variou